Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 22

Results For "Inke"

273 News Found

Govt earmarks Rs 500 crore for pharma clusters and MSMEs
Policy | March 12, 2022

Govt earmarks Rs 500 crore for pharma clusters and MSMEs

Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers releases guidelines for the scheme


Medical devices production under PLI scheme gets off the ground
News | March 10, 2022

Medical devices production under PLI scheme gets off the ground

A total of 21 applicants have been approved for 49 products, with the potential to utilize an incentive amount of Rs. 2541 crore


Molecular Health and researchers prove new approach to anticipate molecular causation
Biotech | March 10, 2022

Molecular Health and researchers prove new approach to anticipate molecular causation

The studies demonstrate a standardized strategy to extend mechanistic modeling and systems pharmacology into drug safety and mode of action assessments that has relevance for drug development and a variety of other contexts


IOL Chemicals and Pharmaceuticals to limit capex at Rs 150 crore per year
News | March 07, 2022

IOL Chemicals and Pharmaceuticals to limit capex at Rs 150 crore per year

The company already has the world’s largest capacity for ibuprofen and is now looking at expansion in new molecules as the idea is to actually de-risk the business


Limited impact of short-term disruptions, growth momentum to continue in FY 23
News | March 03, 2022

Limited impact of short-term disruptions, growth momentum to continue in FY 23

Large players are adequately capitalised to make bigger investments to adjust for the ongoing fundamental shift in market opportunities


Diversification by pharma companies critical to repositioning supply chain
News | March 02, 2022

Diversification by pharma companies critical to repositioning supply chain

Technology adoption helped the industry to sail through Covid-19 disruption as it understood the need to digitize, learn, and excel


Cabinet approves Ayushman Bharat Digital Mission at an outlay of Rs 1,600 cr.
Policy | February 27, 2022

Cabinet approves Ayushman Bharat Digital Mission at an outlay of Rs 1,600 cr.

Citizens will be able to create their ABHA (Ayushman Bharat Health Account) numbers, to which their digital health records can be linked


GliaPharm SA collaborate with Wyss Centre for Alzheimer therapy
Biotech | February 25, 2022

GliaPharm SA collaborate with Wyss Centre for Alzheimer therapy

The collaboration will accelerate the testing of GliaPharm’s lead molecules in preclinical models of Alzheimer’s disease and further the development of neuroimaging biomarkers


Industry needs to ensure quality standards : S Aparna, Union Pharma Secretary
News | February 24, 2022

Industry needs to ensure quality standards : S Aparna, Union Pharma Secretary

Collaboration in the industry needs to be institutionalised to drive the growth.


ACUITE upgrades ratings of Bal Pharma
News | February 23, 2022

ACUITE upgrades ratings of Bal Pharma

The group had witnessed healthy revenue growth as revenue stood at Rs 251.14 crore in FY21.